biomedicina slovenica

"IMMUNOTHERAPY" : 145-244

  1. Eržen R; Bajrović N; Mušič E; Košnik M
    Efficiency of wasp venom specific immunotherapy in patients with allergic reactions to European hornet sting
    2009 ►
  2. Kopač P; Zidarn M; Bajrović N; Eržen R; Adamič K; Košnik M; Mušič E
    Safety of specific immunotherapy using ultra-rush 150-min induction scheme in hymenoptera venom allergy
    2009 ►
  3. Bezeljak M
    Sublingvalna imunoterapija
    [Sublingual allergen immunotherapy]
    2009 ►
  4. Adamič Katja; Zidarn Mihaela; Bajrović Nissera; Eržen Renato; Kopač Peter; Mušič Ema
    The local and systemic side-effects of venom and inhaled -allergen subcutaneous immunotherapy
    2009 ►
  5. Tevž Gregor
    Kombinirano zdravljenje eksperimentalnih mišjih tumorjev SA-1 in LPB z elektrotransfekcijo gena IL-12 in obsevanjem
    [Combined treatment of murine experimental tumors SA-1 and LPB by IL-12 gene electrotransfer and ionizing radiation]
    2009 ►
  6. Terzis A Jorge A; Niclou Simone P; Rajčević Uroš; Danzeisen Claude; Bjerkvig Rolf
    Cell therapies for glioblastoma
    2006 ►
  7. Kamenšek Urška; Serša Gregor
    Targeted gene therapy in radiotherapy
    [Ciljana genska terapija v radioterapiji]
    2008 ►
  8. Žitnik S; Glavnik V; Avčin T; Accetto M; Toplak N; Šilar M; Košnik M; Korošec P
    High sensitivity of basophils predicts side effects in bee venom immunotherapy in children
    2008 ►
  9. Kopač P; Adamič K; Zidarn M; Eržen R; Bajrović N; Košnik M; Mušič E
    Shorter ultra rush immunotherapy protocol for Hymenoptera sting allergy is not associated with higher frequency of side effects
    2008 ►
  10. Lalek N; Šilar M; Eržen R; Košnik M; Korošec P
    IgG induced basophil desensitisation during birch pollen immunotherapy
    2008 ►
  11. Peternelj A; Šilar M; Eržen R; Košnik M; Korošec P
    Predicting efficacy of venom immunotherapy with basophil activation test
    2008 ►
  12. Košnik M; Štalc B; Mušič E; Bajrović N; Eržen R; Zidarn M; Mesić M; Mežnar B; Kafol-Šušteršič A; Hudoklin I; Lopert A; Kecelj P; Devčič B; Zalokar P
    Slovenian study of sublingual immunotherapy
    2008 ►
  13. Zidarn M
    Mechanisms of immunotherapy
    2008 ►
  14. Peternelj A; Šilar M; Eržen R; Košnik M; Korošec P
    Correlation between basophil specific sensitivity and efficiancy of venom immunotherapy
    2008 ►
  15. Žitnik S; Glavnik V; Avčin T; Accetto M; Toplak N; Šilar M; Korošec P
    High sensitivity of basophils predict side effect in bee venom immunotherapy in children
    2008 ►
  16. Zidarn M; Košnik M; Šilar M; Korošec P
    Changes in basophil reactivity during grass pollen immunotherapy
    2008 ►
  17. Šilar M; Lalek N; Eržen R; Košnik M; Korošec P
    Basophil resposiveness during birch pollen immunotherapy
    2008 ►
  18. Moesges Ralph; Bruening Herald; Hessle Hans-Jürgen; Goetz Gerhardt; Knaussmann Hans-Georg
    Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: #a #randomized controlled trial
    2007 ►
  19. Peternelj Andreja; Šilar Mira; Eržen Renato; Bajrović Nisera; Mušič Ema; Košnik Mitja; Korošec Peter
    Test aktivacije bazofilcev (BAT) in vitro diagnostike pri preobčutljivosti za strup kožekrilcev
    [Basophil activation test (BAT) in "in vitro" diagnosis of hymenoptera venom hypersensitivity]
    2008 ►
  20. Peternelj Andreja; Šilar Mira; Eržen Renato; Košnik Mitja; Korošec Peter
    Basophil sensitivity in patients not responding to venom immunotherapy
    2008 ►
  21. Hafner Tomaž; DuBuske Lawrence; Košnik Mitja
    Long-term efficacy of venom immunotherapy
    2008 ►
  22. Čamernik M
    Specifična imunoterapija
    [Specific allergen immunotherapy]
    2007 ►
  23. Mušič E; Bajrović N; Eržen R; Kecelj P
    Six-year analysis of venom immunotherapy (VIT) and its side effects
    2007 ►
  24. Korošec P; Košnik M
    Predicting side-effects in venom immunotherapy by basophil activation: basophil sensitivity vs maximal response
    2007 ►
  25. Zidarn M; Košnik M; Drinovec I
    Anaphylaxis after Hymenoptera sting without detectable specific IgE
    2007 ►
  26. Jezeršek-Novaković Barbara; Kotnik Vladimir; Južnič-Šetina Tanja; Vovk Marjeta; Novaković Srdjan
    Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma
    [Ugotavljanje mehanizmov delovanja rituksimaba in klinični rezultati pri vsioko rizičnih bolnikih z agresivnimi CD20+ limfomi]
    2007 ►
  27. Bajrović Nisera
    Organizacija in zagotavljanje kakovosti imunoterapije
    2006 ►
  28. Žitnik Simona Eva; Bajrović Nisera; Acetto Meta
    Zapleti vzdrževalne imunoterapije pri žuželkah
    2006 ►
  29. Košnik Mitja
    Alergijski rinitis: je bolan nos ali bolnik? Kako dolgo je predolgo?
    2006 ►
  30. Košnik Mitja
    Management of patients with Hymenoptera venom hypersensitivity
    [Praćenje bolesnika alergičnih na otrove opnokrilaca (Hymenoptera)]
    2006 ►
  31. Tudorović N; Turkalj M
    Specifična imunoterapija u alergijskim bolestima. Posljediplomski tečaj trajno medicinskog usavršavanja I. kategorije; 2006 ruj 16; Zagreb
    2006 ►
  32. Konatschnig Thomas; Geis Nicolas; Schultz Stefan; Kirschfink Michael
    Complement resistance impairs anti-tumour therapy
    [Odpornost na komplement ovira onkološko zdravljenje]
    2006 ►
  33. Eržen R; Šilar M; Korošec P
    Determination of serum tryptase is not a useful predictor of individual risks of side effects to venom immunotherapy
    2006 ►
  34. Peternelj A; Šilar M; Korošec P; Košnik M
    Basophil sensivity and protection of patients after completed venom immunotherapy
    2006 ►
  35. Šilar M; Peternelj A; Eržen R; Košnik M; Korošec P
    Basophil specific sensivity during venom immunotherapy
    2006 ►
  36. Hafner Tomaž
    Dolgoročna učinkovitost zdravljenja z imunoterapijo bolnikov, preobčutljivih za strup kožokrilcev
    [Long-term efficiency of treatment with immunotherapy of patients allergic to insect venom]
    2006 ►
  37. Peternelj Andreja; Šilar Mira; Košnik Mitja; Korošec Peter
    Basophil sensitivity in patients not responding to venom immunotherapy
    2006 ►
  38. Oven Irena
    MHC class II molecules and tumour immunotherapy
    [Pomen molekul MHC pri imunoterapiji tumorjev]
    2005 ►
  39. Hafner Tomaž
    Dolgoročna učinkovitost zdravljenja z imunoterapijo bolnikov, preobčutljivih za strup kožokrilcev
    2005 ►
  40. Koren-Jeverica Anja; Glavnik V
    Alergijski rinokonjunktivitis
    [Allergic rhinoconjunctivitis]
    2005 ►
  41. Peternelj Andreja; Šilar Mira; Korošec Peter; Košnik Mitja
    Basophil sensivity and protection of patients after insect venom immunotherapy
    2005 ►
  42. Camlek Luka
    Specific pollen immunotheraphy and destiny of cross reactivity
    2005 ►
  43. Košnik M; Šilar M; Bajrović N; Mušič E; Korošec P
    High sensitivity of basophils predicts side-effects in venom immunotherapy
    2005 ►
  44. Pretnar Jože
    Novi načini zdravljenja najpogostejših limfatičnih novotvorb
    [The new treatments of the most frequent malignant lymphoproliferative disorders]
    2005 ►
  45. Košnik Mitja
    Alergija za strupe žuželk
    [The alergy to insect poisons]
    2005 ►
  46. Košnik Mitja
    Management of patients with venom hypersensitivity
    2005 ►
  47. Košnik Mitja; Glavnik Vesna
    Alergija za strupe žuželk
    2005 ►
  48. Košnik Mitja
    Specifična imunoterapija (SIT)
    2005 ►
  49. Košnik M; Šilar M; Bajrović N; Korošec P
    High sensitivity of basophils predicts systemic adverse effects from venom immunotherapy
    2005 ►
  50. Repnik Urška
    Zorenje dendritičnih celic in njihov vpliv v alogenskem imunskem odzivu in vitro
    [Dendritic cell maturation and their influence in in vitro allogeneic immune response]
    2005 ►
  51. Vidergar-Kralj Barbara
    Nuklearna medicina
    2004 ►
  52. Takač Iztok
    Research work at the Department of gynecologic and breast oncology of Maribor teaching hospital
    2004 ►
  53. Hafner Tomaž; Košnik Mitja
    Long-term effectiveness of immunotherapy od patients allergic to insect venoms
    2004 ►
  54. Jurin Mislav
    Tumor immunology - from experiment to clinical application
    [Tumorska imunologija - od poskusov do klinične uporabe]
    2004 ►
  55. Schirrmacher Volker
    T-cell immunity controlling tumor dormancy
    [Limfociti T uravnavajo latentnost tumorjev]
    2004 ►
  56. Košnik Mitja; Korošec Peter; Mušič Ema
    Hot topics in venom hypersensitivity
    [Sodobni pogledi na preobčutljivost za strupe kožokrilcev]
    2004 ►
  57. Beckhove Phillip; Fuerer Markus; Schuetz Florian; Dolenc Mathias; Choi Carmen; Sommerfeldt Nora; Schwendemann Jochen; Ehlert Kathrin; Altevogt Peter; Bastert Gunther
    Memory T cells as a new tool for tumor immunotherapy
    [Spominske celice T - novo orodje za imunsko zdravljenje tumorjev]
    2004 ►
  58. Novaković Srdjan
    A brief overview of the current status of tumor vaccines and our experience in this line of work
    [Kratek pregled tumorskih cepiv in naše izkušnje]
    2004 ►
  59. Fleischmann William Robert; Wu Tzu G
    Development of a vaccine against cancers
    [Razvoj cepiva proti raku]
    2004 ►
  60. Wraber Branka; Šega Saša; Kocjan Tomaž; Košnik Mitja; Repnik Urška; Bilač-Krašnja Mojca
    Citokinski odzivi pri različnih imunointervencijah - podobnosti in razlike
    [Cytokine responses in different immunointerventions - similarities and differences]
    2004 ►
  61. Ihan Alojz
    Spremljanje imunomodulatornih učinkov s pretočno citometrijo - govorica limfocitnih populacij
    [Following immunomodulatory effects using flow cytometry - the language of lymphocyte subsets]
    2004 ►
  62. Bremberg Stefan; Nilstun Tore; Kovač Vili; Zwitter Matjaž
    GPs facing reluctant and demanding patients: analysing ethical justifications
    2003 ►
  63. Košnik M; Mušič E; Sager A
    Comparison of potency and safety of two hymenoptera venom extracts
    2004 ►
  64. Novaković Srdjan
    Current status in the field of tumor vaccines
    2003 ►
  65. Mole Helena; Štucin-Gantar Irena; Kornhauser-Cerar Lilijana; Babnik Janez
    Okužbe z bakterijo Streptococcus agalactiae pri novorojencih
    [Neonatal GBS infections]
    2004 ►
  66. Arnež Maja
    Okužbe s Streptococcus agalactiae: pogostost, diagnostika in možnost preprečevanja
    [Streptococcus agalactiae infections: incidence, diagnosis and prevention]
    2004 ►
  67. Jezeršek-Novaković Barbara; Vovk Marjeta; Borštnar Simona; Tomšič Radka
    Rituximab affects the prognosis of patients with nonHodgkin's lymphomas
    [Rituximab spreminja prognozo bolnikov z neHodgkinovimi limfomi]
    2004 ►
  68. Grle-Popović Sanja; Kljajić-Turkalj Mirjana; Kotrulja Lena; Pavičič Fadila; Rožman Alma; Stipić Asja; Tudorić Neven; Košnik Mitja
    Živeti z alergijskimi boleznimi
    2004 ►
  69. Košnik Mitja
    Zapleti imunoterapije
    2004 ►
  70. Strojan Milan
    Alergije pri otrocih
    2001 ►
  71. Košnik Mitja; Glavnik Vesna
    Alergija za strupe žuželk
    2004 ►
  72. Košnik Mitja
    Specifična imunoterapija (SIT)
    2004 ►
  73. Čamernik Maja; Mehić Hasiba
    Specifična imunoterapija
    2003 ►
  74. Kuhar Marijana
    Alergijske reakcije na strupe kožokrilcev
    2003 ►
  75. Eržen R; Bajrović N; Mušič E; Košnik M
    Comparison of rush and ultra rush hymenoptera venom immunotherapy
    2003 ►
  76. Flandre P; O'Quigley J
    A two-stage procedure for survival studies with surrogate endpoints
    1995 ►
  77. Košnik Mitja; Wraber Branka; Grmek Irena
    Rush Hymenoptera venom immunotherapy modulates mast cell and basophil function
    2003 ►
  78. Štabuc Borut
    Sistemsko zdravljenje raka trebušne slinavke
    [Chemotherapy for pancreatic cancer]
    2002 ►
  79. Borštnar Simona
    Klinični primer (ne-Hodgkinov limfom, difuzni, velikocelični, B celični): bolnica T. R., 47 let
    2002 ►
  80. Košnik Mitja; Korošec Peter; Šilar Mira; Mušič Ema; Eržen Renato
    Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting
    2002 ►
  81. Košnik M; Mušič E
    Safety of Venomenhal (HAL) in maintenance of hymenoptera venom immunotherapy
    2002 ►
  82. Kuhar Marijana
    Alergijski rinitis pri otrocih in vpliv na razvoj astme
    [Allergic rhinitis in children and its effect on development of asthma]
    2002 ►
  83. Porenta-Bešić Vlasta
    Specifična imunoterapija
    2002 ►
  84. Novaković Srdjan; Jezeršek-Novaković Barbara
    A brief overview of the tumor vaccines through the last decade
    [Kratek pregled priprave tumorskih vakcin v zadnjem desetletju]
    2002 ►
  85. Košnik Mitja; Mušič Ema; Sager Angelika
    Safety of venomenhal venom in maintenance Hymenoptera venom immunotherapy
    [Varnost pripravka venomenhal za vzdrževalno imunoterapijo bolnikov, alergičnih na strupe kožekrilcev]
    2001 ►
  86. Jeras Matjaž; Repnik Urška; Zorec Robert; Grilc Sonja; Kreft Marko; Knežević Miomir
    Dendritic cells and their potential use in cancer immunotherapy
    2001 ►
  87. Kraut A
    Oko in alergija pri otroku
    [Eye and allergy in children]
    2000 ►
  88. Košnik M; Eržen R; Korošec P; Mušič E
    Immunotherapy of patients who experienced allergic reaction following european hornets (Vespa crabro) sting
    2001 ►
  89. Yovtchev Yovtcho; Nikolov Stoian
    Opportunities for up to date treatment of the colorectal cancer
    [Možnosti sodobnega zdravljenja karcinoma debelega črevesa in danke]
    2001 ►
  90. Derganc Metka
    Novosti v diagnostiki in zdravljenju sepse pri otrocih
    2001 ►
  91. Čufer Tanja
    Sistemsko zdravljenje raka
    2000 ►
  92. Štabuc Borut
    Zdravljenje raka trebušne slinavke z obsevanjem in kemoterapijo
    [Chemotherapy and radiotherpay for pancreatic cancer]
    2001 ►
  93. Ocvirk J; Štabuc B; Rudolf Z; Galvani V; Čurin-Šerbec V
    Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients
    2000 ►
  94. Ihan Alojz; Peček Andreja
    Imunski sistem in odpornost: kako se ubranimo bolezni
    2000 ►
  95. Košnik Mitja; Mušič Ema
    Safety of Venomenhal in maintenance hymenoptera venom immunotherapy
    2000 ►
  96. Mušič Ema
    Efficacy of specific immunotherapy in hay fever
    2000 ►
  97. Eržen R; Mušič E; Košnik M
    Safety of hymenoptera venom immunotherapy
    2000 ►
  98. Rudolf Z
    Intralesional immunotherapy with BCG in metastatic malignant melanoma-preliminary results
    1980 ►
  99. Plesničar S; Rudolf Z
    IMMUNOTHERAPY OF MALIGNANT MELANOMA
    1981 ►
  100. Rudolf Z; Plesničar S
    COMBINED MODALITY TREATMENT OF MALIGNANT MELANOMA (CHEMOTHERAPY, RADIOTHERAPY, IMMUNOTHERAPY)
    1981 ►

   1 45 145 245  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics